Published 1 day ago • loading... • Updated 1 day ago

Merck’s new drug development moving forward, sales increase

Summary by WFMZ

Merck’s therapeutic cancer vaccine is now in Phase 3 testing, which means it’s being used on humans, and one test has proven successful.

1 Articles

WFMZ

Center

Merck’s new drug development moving forward, sales increase

Merck’s therapeutic cancer vaccine is now in Phase 3 testing, which means it’s being used on humans, and one test has proven successful.

1 day ago·Pennsylvania, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated1 day agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

WFMZ broke the news in Pennsylvania, United States 1 day ago on Thursday, October 29, 2026.

Sources are mostly out of (0)

Merck’s new drug development moving forward, sales increase

1 Articles

1 Articles

Merck’s new drug development moving forward, sales increase

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Merck & Co., Inc. (NYSE:MRK) Releases Earnings Results

Merck tops third-quarter estimates as Keytruda, Gardasil outperform

Paolillo (Merck), in Neurology Next to Patients, From Multiple Sclerosis to Rare Diseases For

Trump on Iran war: It's going to get wrapped up soon

A Minnesota prison was for sale at $75M. ICE paid nearly $500M for it

Japan demands release of national in meeting with Russia's Lavrov

Similar News Topics

Similar News Topics

More stories like this

Merck & Co., Inc. (NYSE:MRK) Releases Earnings Results

Merck tops third-quarter estimates as Keytruda, Gardasil outperform

Paolillo (Merck), in Neurology Next to Patients, From Multiple Sclerosis to Rare Diseases For

Trump on Iran war: It's going to get wrapped up soon

A Minnesota prison was for sale at $75M. ICE paid nearly $500M for it

Japan demands release of national in meeting with Russia's Lavrov

Merck’s new drug development moving forward, sales increase

1 Articles

1 Articles

Merck’s new drug development moving forward, sales increase

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Merck & Co., Inc. (NYSE:MRK) Releases Earnings Results

Merck tops third-quarter estimates as Keytruda, Gardasil outperform

Paolillo (Merck), in Neurology Next to Patients, From Multiple Sclerosis to Rare Diseases For

Trump on Iran war: It's going to get wrapped up soon

A Minnesota prison was for sale at $75M. ICE paid nearly $500M for it

Japan demands release of national in meeting with Russia's Lavrov

Similar News Topics

Similar News Topics

More stories like this

Merck & Co., Inc. (NYSE:MRK) Releases Earnings Results

Merck tops third-quarter estimates as Keytruda, Gardasil outperform

Paolillo (Merck), in Neurology Next to Patients, From Multiple Sclerosis to Rare Diseases For

Trump on Iran war: It's going to get wrapped up soon

A Minnesota prison was for sale at $75M. ICE paid nearly $500M for it

Japan demands release of national in meeting with Russia's Lavrov

Bias Distribution

Factuality